IMMUNOLOGY MARKET ANALYSIS

Immunology Market, By Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody, Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025
Code : CMI4594
Pages :179
Formats :
Excel and PDF
Industry : Pharmaceutical

Immunology Market Size and Trends

Global immunology market is estimated to be valued at USD 108.49 Bn in 2025 and is expected to reach USD 246.04 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032.

Immunology Market Key Factors

To learn more about this report, Request sample copy

Global immunology market is expected to witness significant growth over the forecast period due to factors such as high prevalence of autoimmune and immunology disorders, rising demand for monoclonal antibodies and immunotherapy, and strong pipeline of immunology drugs. Increasing healthcare expenditures and availability of research funds for immunology research globally Can also drive the market growth.

Rising Prevalence of Autoimmune Diseases

Increasing prevalence of various autoimmune diseases across the globe can drive the immunology market growth. Autoimmune diseases occur when the body's immune system mistakenly attacks and destroys healthy body tissues. Some of the most common autoimmune disorders include rheumatoid arthritis, Type 1 diabetes, multiple sclerosis, inflammatory bowel disease, psoriasis, lupus and others. For instance, in February 2022, according to the data from Canadian Cancer Statistics Report, 233,900 persons were diagnosed with cancer in 2022. The most common cancers, according to the research, are colon, prostate, and breast cancers. When combined, these represent about 50% of all common instances. Due to high incidence of cancer in nations like Canada, there has been increase in research activities to produce new medications.